Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Decoding the RNA Editome of Normal Versus Malignant Progenitor Cell Aging Short Title: RNA Editing in Normal Aging and MDS/AML Stem Cells

Leslie A Crews, PhD, Qingfei Jiang, PhD, Larisa Balaian, PhD, Heather Leu, BS, Nathan Delos Santos, Angela C Court, Anil Sadarangani, PhD, Sheldon Morris, MD, Rainer F. Storb, MD, Anna Kulidjian, MD, Edward D. Ball, MD, Catriona Jamieson, MD PhD

Blood (2016) 128 (22): 1519.

https://doi.org/10.1182/blood.V128.22.1519.1519

Published: 2016

Journal Articles

Reversion to an Embryonic Alternative Splicing Program Enhances Leukemia Stem Cell Self-Renewal

Frida Linnea Holm, PhD, Eva Hellqvist, PhDMSc, Cayla N Mason, BS, Shawn Ali, BA, Nathaniel Delos Santos, Christian Barrett, Hye-Jung Chun, Mark D. Minden, MD PhD, Moore Richard, Marco A Marra, PhD, Kelly A. Frazer, Anil Sadarangani, PhD, Catriona Jamieson, MD PhD

Blood (2015) 126 (23): 1227.

https://doi.org/10.1182/blood.V126.23.1227.1227

Published: 2015

Journal Articles

RNA Splicing Modulation Impairs Acute Myeloid Leukemia Stem Cell Maintenance

Leslie A Crews, PhD, Larissa Balaian, PhD, Heather Leu, BS, Nathaniel Delos Santos, Angela C Court, Anil Sadarangani, PhD, Maria A. Zipeto, PhD, James J La Clair, Reymundo Villa, Sheldon Morris, MD, Rainer F. Storb, MD, Anna Kulidjian, MD, Edward D. Ball, MD, Michael D Burkart, PhD, Catriona Jamieson, MD PhD

Blood (2015) 126 (23): 567.

https://doi.org/10.1182/blood.V126.23.567.567

Published: 2015

Journal Articles

Malignant Reprogramming of Progenitors into Leukemia Stem Cells Is Enhanced By Upregulation of CD44 Transcript Variant 3 in Malignant Microenvironments

Frida L Holm, PhD, Eva Hellqvist, PhD, Cayla N Mason, BS, Christian L Barrett, PhD, Shawn Ali, BA, Hye-Jung Chun, MSc, Marco A. Marra, PhD, Valeria Runza, Kelly A Frazer, PhD, Anil Sadarangani, PhD, Catriona Jamieson, MD PhD

Blood (2014) 124 (21): 511.

https://doi.org/10.1182/blood.V124.21.511.511

Published: 2014

Journal Articles

Cirmtuzumab Vedotin (UC-961ADC3), An Anti-ROR1-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment For ROR1-Positive Leukemia and Solid Tumors

Bing Cui, Ph.D, George F. Widhopf, II, PhD, Charles E. Prussak, Ph.D., Christina C.N. Wu, PhD, Anil Sadarangani, PhD, Suping Zhang, PhD, Fitzgerald Lao, Catriona HM Jamieson, MD, PhD, Dennis A. Carson, M.D, Thomas J. Kipps, MD, PhD

Blood (2013) 122 (21): 1637.

https://doi.org/10.1182/blood.V122.21.1637.1637

Published: 2013

Journal Articles

The Role Of CD44 Isoform Expression In Niche Resident Chronic Myeloid Leukemia Stem Cell Evolution

Cayla Mason, BSc, Frida Holm, PhD, Eva Hellqvist, PhD, Christian Barrett, PhD, Kelly A Frazer, Ph.D., Anil Sadarangani, PhD, Catriona HM Jamieson, MD, PhD

Blood (2013) 122 (21): 4028.

https://doi.org/10.1182/blood.V122.21.4028.4028

Published: 2013

Journal Articles

CD44 Monoclonal Antibody-Enhanced Clearance Of Chronic Myeloid Leukemia Stem Cells From The Malignant Niche

Eva Hellqvist, PhD, Frida Holm, PhD, Cayla N Mason, BS, Valeria Runza, Stefan Weigand, Anil Sadarangani, PhD, Catriona H.M. Jamieson, M.D., Ph.D.

Blood (2013) 122 (21): 858.

https://doi.org/10.1182/blood.V122.21.858.858

Published: 2013

Journal Articles

Treatment With Hedgehog Inhibitor, PF-04449913, Attenuates Leukemia-Initiation Potential In Acute Myeloid Leukemia Cells

Nobuaki Fukushima, MD, Yosuke Minami, MD, PhD, Fumihiko Hayakawa, MD, PhD, Hitoshi Kiyoi, MD, PhD, Anil Sadarangani, PhD, Catriona HM Jamieson, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2013) 122 (21): 1649.

https://doi.org/10.1182/blood.V122.21.1649.1649

Published: 2013

Journal Articles

Inhibition Of Inflammation Driven Leukemia Stem Cell Self-Renewal With a Selective JAK2 Antagonist

Angela C Court Recart, BS, MS, Anil Sadarangani, PhD, Elizabeth Chun, MSc, Cayla N Mason, BS, Qingfei Jiang, PhD, Christian L Barrett, Ph.D., Russell Wall, BS, Daniel J Goff, PhD, Ifat Geron, MSc, Alice Shih, Heather S. Leu, B.S., Wenxue Ma, M.D., Ph.D., Mark D. Minden, MD PhD, Kelly A Frazer, Ph.D., Marco A. Marra, PhD, Leslie A Crews, PhD, Catriona HM Jamieson, MD, PhD

Blood (2013) 122 (21): 1481.

https://doi.org/10.1182/blood.V122.21.1481.1481

Published: 2013

Journal Articles

Targeting Of Chronic Lymphocytic Leukemia B Cells With a Humanized Monoclonal Antibody Specific For ROR1

George F. Widhopf, II, PhD, Bing Cui, Ph.D., Christina C.N. Wu, PhD, Jian Yu, PhD, Fitzgerald Lao, Rommel Tawatao, Rongrong Wu, Esther Avery, B.S., Anil Sadarangani, PhD, Charles Prussak, PhD, Catriona HM Jamieson, MD, PhD, Dennis A. Carson, M.D., Thomas J. Kipps, MD, PhD

Blood (2013) 122 (21): 2873.

https://doi.org/10.1182/blood.V122.21.2873.2873

Published: 2013

Journal Articles

Combined JAK/STAT5A and BCR-ABL Inhibition Impairs Blast Crisis Chronic Myeloid Leukemia Stem Cell Self-Renewal

Angela C Court Recart, BS, MS, Daniel J Goff, PhD, Anil Sadarangani, Ph.D., Cayla N Mason, BS, Alice Y. Shih, B.S., Russell Wall, BS, Heather S. Leu, B.S., Wenxue Ma, M.D., Ph.D., Hye-Jung Chun, MSc, Marco A. Marra, PhD, Christian L Barrett, Ph.D., Kelly A Frazer, Ph.D., Catriona Jamieson, MD, PhD

Blood (2012) 120 (21): 910.

https://doi.org/10.1182/blood.V120.21.910.910

Published: 2012

Journal Articles

Selective Clearance of Chronic Lymphocytic Leukemia Cells in Vivo Following Treatment with UC99961, an Anti-ROR1 Monoclonal Antibody

Eva Hellqvist, Ph.D, Christina C.N. Wu, Ph.D., George F. Widhopf, II, PhD, Alice Shih, Rommel Tawatao, Fitzgerald Lao, Bing Cui, Ph.D., Charles Prussak, PhD, Anil Sadarangani, Ph.D., Dennis A. Carson, M.D., Catriona Jamieson, MD, PhD, Thomas J. Kipps, MD, PhD

Blood (2012) 120 (21): 3886.

https://doi.org/10.1182/blood.V120.21.3886.3886

Published: 2012

Journal Articles

Sabutoclax, a Novel Pan BCL2 Family Inhibitor, Sensitizes Dormant Blast Crisis Chronic Myeloid Leukemia Stem Cells to Dasatinib

Heather S. Leu, B.S., Daniel J Goff, PhD, Janine Low-Marchelli, PhD, Angela C Court Recart, BS, MS, Kristen M. Smith, Ph.D., Wenxue Ma, M.D., Ph.D., Anil Sadarangani, Ph.D., Alice Y. Shih, B.S., Jun Wei, Ph.D., Dayong Zhai, Ph.D., Jason Gotlib, M.D., M.S., Mark D. Minden, MD, PhD, Giovanni Martinelli, MD, Marco A. Marra, PhD, Kelly A Frazer, Ph.D., Maurizio Pellecchia, PhD, John C. Reed, MD, PhD, Catriona Jamieson, MD, PhD

Blood (2012) 120 (21): 3739.

https://doi.org/10.1182/blood.V120.21.3739.3739

Published: 2012

Journal Articles

A Highly Selective Anti-ROR1 Monoclonal Antibody Inhibits Human Acute Myeloid Leukemia CD34+ Cell Survival and Self-Renewal.

Larissa Balaian, Ph.D., Anil Sadarangani, Ph.D., George F. Widhopf, II, PhD, Rui-kun Zhong, MD, Charles Prussak, PhD, Marco A. Marra, PhD, John E Dick, PhD, Mark D. Minden, MD, PhD, Edward D. Ball, M.D., Dennis A. Carson, M.D., Catriona Jamieson, MD, PhD, Thomas J. Kipps, MD, PhD

Blood (2012) 120 (21): 2560.

https://doi.org/10.1182/blood.V120.21.2560.2560

Published: 2012

Journal Articles

The RNA Editase ADAR1 Promotes Malignant Progenitor Reprogramming in Chronic Myeloid Leukemia.

Qingfei Jiang, Ph.D., Leslie Crews-Robertson, PhD, Christian L Barrett, Ph.D., Hyn-June Chun, Angela C. Court-Recart, M.S., Daniel J Goff, PhD, Mark D. Minden, MD, PhD, Anil Sadarangani, Ph.D., Jessica Rusert, B.S., Kim-Hien Dao, DO, PhD, Sheldon R Morris, MD, MPH, Lawrence S. B. Goldstein, Ph.D., Marco A. Marra, PhD, Kelly A Frazer, Ph.D., Catriona Jamieson, MD, PhD

Blood (2012) 120 (21): 2772.

https://doi.org/10.1182/blood.V120.21.2772.2772

Published: 2012

Journal Articles

BCL2 Splice Isoform Switching Promotes Leukemia Stem Cell Survival and Sensitivity to a Novel Pan BCL2 Inhibitor

Blood (2011) 118 (21): 2735.

https://doi.org/10.1182/blood.V118.21.2735.2735

Published: 2011

Journal Articles

Cycling Toward Leukemia Stem Cell Elimination Wtih a Selective Sonic Hedgehog Antagonist,

Blood (2011) 118 (21): 3776.

https://doi.org/10.1182/blood.V118.21.3776.3776

Published: 2011

Journal Articles

NOTCH1 Signaling Defines a Leukemia Initiating Cell Population in T-Cell Acute Lymphoblastic Leukemia

Wenxue Ma, M.D., Ph.D., Kristen M. Smith, Ph.D., Alejandro Gutierrez, M.D., Heather S. Leu, B.S., Qingfei Jiang, Ph.D., Christina C.N. Wu, Ph.D., Alice Y. Shih, B.S., Angela C. Court-Recart, M.S., Anil Sadarangani, Ph.D., Daniel J. Goff, B.S., Ping Wei, Ph.D., A. Thomas Look, M.D., Catriona H.M. Jamieson, M.D., Ph.D.

Blood (2011) 118 (21): 1507.

https://doi.org/10.1182/blood.V118.21.1507.1507

Published: 2011

Journal Articles

Combination Targeted Therapy to Impair Self-Renewal Capacity of Human Blast Crisis Leukemia Stem Cells

Angela C Court Recart, BS, MS, Anil Sadarangani, Ph.D., Daniel Goff, BS, Alice Y Shih, BS, Russell Wall, BS, Heather Leu, BS, Wenxue Ma, M.D., Ph.D., Christian L Barrett, Ph.D., Kelly A Frazer, Ph.D., Elizabeth Chun, MSc, Marco A. Marra, PhD, Catriona Jamieson, MD, Ph.D.

Blood (2011) 118 (21): 1693.

https://doi.org/10.1182/blood.V118.21.1693.1693

Published: 2011

Journal Articles

A Notch Mutational Hierarchy Among Human T-ALL Leukemia Stem Cells.

Wenxue Ma, MD, PhD, Alejandro Gutierrez, MD, Daniel Goff, BS, Angela Court-Recart, MS, Alice Shih, BS, Qingfei Jiang, Ph.D., Anil Sadarangani, Ph.D., Christina Wu, Ph.D., Christina Jamieson, Ph.D., Mitchell Diccianni, PhD, Ping Wei, Ph.D., Todd Van Arsdale, PhD, Thomas Look, MD, Catriona Jamieson, MD, PhD

Blood (2010) 116 (21): 1034.

https://doi.org/10.1182/blood.V116.21.1034.1034

Published: 2010

NARROW

Decoding the RNA Editome of Normal Versus Malignant Progenitor Cell Aging Short Title: RNA Editing in Normal Aging and MDS/AML Stem Cells

Reversion to an Embryonic Alternative Splicing Program Enhances Leukemia Stem Cell Self-Renewal

RNA Splicing Modulation Impairs Acute Myeloid Leukemia Stem Cell Maintenance

Malignant Reprogramming of Progenitors into Leukemia Stem Cells Is Enhanced By Upregulation of CD44 Transcript Variant 3 in Malignant Microenvironments

Cirmtuzumab Vedotin (UC-961ADC3), An Anti-ROR1-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment For ROR1-Positive Leukemia and Solid Tumors

The Role Of CD44 Isoform Expression In Niche Resident Chronic Myeloid Leukemia Stem Cell Evolution

CD44 Monoclonal Antibody-Enhanced Clearance Of Chronic Myeloid Leukemia Stem Cells From The Malignant Niche

Treatment With Hedgehog Inhibitor, PF-04449913, Attenuates Leukemia-Initiation Potential In Acute Myeloid Leukemia Cells

Inhibition Of Inflammation Driven Leukemia Stem Cell Self-Renewal With a Selective JAK2 Antagonist

Targeting Of Chronic Lymphocytic Leukemia B Cells With a Humanized Monoclonal Antibody Specific For ROR1

Combined JAK/STAT5A and BCR-ABL Inhibition Impairs Blast Crisis Chronic Myeloid Leukemia Stem Cell Self-Renewal

Selective Clearance of Chronic Lymphocytic Leukemia Cells in Vivo Following Treatment with UC99961, an Anti-ROR1 Monoclonal Antibody

Sabutoclax, a Novel Pan BCL2 Family Inhibitor, Sensitizes Dormant Blast Crisis Chronic Myeloid Leukemia Stem Cells to Dasatinib

A Highly Selective Anti-ROR1 Monoclonal Antibody Inhibits Human Acute Myeloid Leukemia CD34+ Cell Survival and Self-Renewal.

The RNA Editase ADAR1 Promotes Malignant Progenitor Reprogramming in Chronic Myeloid Leukemia.

BCL2 Splice Isoform Switching Promotes Leukemia Stem Cell Survival and Sensitivity to a Novel Pan BCL2 Inhibitor

Cycling Toward Leukemia Stem Cell Elimination Wtih a Selective Sonic Hedgehog Antagonist,

NOTCH1 Signaling Defines a Leukemia Initiating Cell Population in T-Cell Acute Lymphoblastic Leukemia

Combination Targeted Therapy to Impair Self-Renewal Capacity of Human Blast Crisis Leukemia Stem Cells

A Notch Mutational Hierarchy Among Human T-ALL Leukemia Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only